Lotus Eye Hospital and Institute Limited
NSE: LOTUSEYE.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Sangeetha Sundaramoorthy
- Employees
- 336
- Headquarters
- Coimbatore, India
- IPO year
- 2008
- Market cap
- ₹2.4B
- Website
- https://www.lotuseye.org
Loading LOTUSEYE…
Loading profile data…Frequently asked questions about LOTUSEYE
What does Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) do?
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraoc...
Where does LOTUSEYE.NS trade?
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) trades on the National Stock Exchange of India.
What sector is LOTUSEYE.NS in?
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Lotus Eye Hospital and Institute Limited?
Sangeetha Sundaramoorthy is the chief executive officer of Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS).
Where is Lotus Eye Hospital and Institute Limited headquartered?
Lotus Eye Hospital and Institute Limited is headquartered in India.
Does LOTUSEYE.NS pay a dividend?
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LOTUSEYE.NS go public?
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) completed its initial public offering in 2008.